Literature DB >> 25540732

Challenges in pediatric renal transplantation.

Licia Peruzzi1, Alessandro Amore1, Rosanna Coppo1.   

Abstract

Transplantation in children is the best option to treat renal failure. Over the last 25 years the improvements in therapy have dramatically reduced the risk of early acute rejection and graft loss, however the long term results in terms of graft survival and morbidity still require search for new immunosuppressive regimens. Tolerance of the graft and minimization of side effects are the challenges for improving the outcome of children with a grafted kidney. Notwithstanding the difficulties in settling in children large multicenter trials to derive statistically useful data, many important contributions in the last years brought important modifications in the immunosuppressive therapy, including minimization protocols of steroids and calcineurin inhibitors and new induction drugs. New methods for diagnosis of anti HLA antibodies and some new protocols to improve both chance and outcome of transplantation in immunized subjects represent area of ongoing research of extreme interest for children.

Entities:  

Keywords:  Acute humoral rejection; Children; Desensitization; Immunosuppressive therapy; Kidney transplantation

Year:  2014        PMID: 25540732      PMCID: PMC4274593          DOI: 10.5500/wjt.v4.i4.222

Source DB:  PubMed          Journal:  World J Transplant        ISSN: 2220-3230


  34 in total

1.  Outcomes after pediatric kidney transplantation improving: how can we do even better?

Authors:  Uptal D Patel
Journal:  Pediatrics       Date:  2014-03-10       Impact factor: 7.124

2.  IVIG and rituximab for treatment of chronic antibody-mediated rejection: a prospective study in paediatric renal transplantation with a 2-year follow-up.

Authors:  Heiko Billing; Susanne Rieger; Caner Süsal; Rüdiger Waldherr; Gerhard Opelz; Elke Wühl; Burkhard Tönshoff
Journal:  Transpl Int       Date:  2012-08-17       Impact factor: 3.782

3.  Alemtuzumab with corticosteroid minimization for pediatric deceased donor renal transplantation: a seven-yr experience.

Authors:  Katarina Supe-Markovina; Jonathan J Melquist; Deirdre Connolly; Heather N DiCarlo; Wayne C Waltzer; Richard N Fine; Frank S Darras
Journal:  Pediatr Transplant       Date:  2014-04-09

4.  Preventing sensitization with mycophenolate mofetil in a pediatric kidney recipient.

Authors:  Hubert Wong; Robert Laberge; Elizabeth Harvey; Guido Filler
Journal:  Pediatr Transplant       Date:  2006-05

5.  Five-year experience using sirolimus-based, calcineurin inhibitor-free immunosuppression in pediatric renal transplantation.

Authors:  Leonard C Hymes; Barry L Warshaw
Journal:  Pediatr Transplant       Date:  2011-02-21

6.  Complete steroid avoidance is effective and safe in children with renal transplants: a multicenter randomized trial with three-year follow-up.

Authors:  M M Sarwal; R B Ettenger; V Dharnidharka; M Benfield; R Mathias; A Portale; R McDonald; W Harmon; D Kershaw; V M Vehaskari; E Kamil; H J Baluarte; B Warady; L Tang; J Liu; L Li; M Naesens; T Sigdel; Janie Waskerwitz; O Salvatierra
Journal:  Am J Transplant       Date:  2012-06-13       Impact factor: 8.086

7.  Efficacy of bortezomib for reducing donor-specific antibodies in children and adolescents on a steroid minimization regimen.

Authors:  Stephanie Nguyen; Brian Gallay; Lavjay Butani
Journal:  Pediatr Transplant       Date:  2014-05-12

8.  Longitudinal growth on an everolimus- versus an MMF-based steroid-free immunosuppressive regimen in paediatric renal transplant recipients.

Authors:  Heiko Billing; Greta Burmeister; Lukasz Plotnicki; Thurid Ahlenstiel; Alexander Fichtner; Anja Sander; Britta Höcker; Burkhard Tönshoff; Lars Pape
Journal:  Transpl Int       Date:  2013-07-19       Impact factor: 3.782

9.  Posttransplant de novo donor-specific hla antibodies identify pediatric kidney recipients at risk for late antibody-mediated rejection.

Authors:  F Ginevri; A Nocera; P Comoli; A Innocente; M Cioni; A Parodi; I Fontana; A Magnasco; A Nocco; A Tagliamacco; A Sementa; P Ceriolo; L Ghio; M Zecca; M Cardillo; G Garibotto; G M Ghiggeri; F Poli
Journal:  Am J Transplant       Date:  2012-09-07       Impact factor: 8.086

10.  A closer look at rituximab induction on HLA antibody rebound following HLA-incompatible kidney transplantation.

Authors:  Annette M Jackson; Edward S Kraus; Babak J Orandi; Dorry L Segev; Robert A Montgomery; Andrea A Zachary
Journal:  Kidney Int       Date:  2014-07-23       Impact factor: 10.612

View more
  3 in total

1.  Renovascular hypertension: results in adulthood of renal autotransplantation performed in children.

Authors:  Bertrand Chavent; Ambroise Duprey; Marie-Pierre Lavocat; Christine Fichtner; Anne-Marie Beraud; Jean-Noel Albertini; Jean-Pierre Favre; Nicolas Maillard; Xavier Barral
Journal:  Pediatr Nephrol       Date:  2017-04-20       Impact factor: 3.714

2.  Pediatric Nephrology in Primary Care: The Forest for the Trees.

Authors:  Donald E Greydanus; Vimal Master Sankar Raj; Joav Merrick
Journal:  Front Public Health       Date:  2015-10-06

3.  Pediatric kidney transplantation is different from adult kidney transplantation.

Authors:  Min Hyun Cho
Journal:  Korean J Pediatr       Date:  2018-07-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.